Tafamidis

Based on 298 reference(s) in Google Scholar 8 10 298

Axon 3533

CAS [594839-88-0]

MF C14H7Cl2NO3
MW 308.12

  • Purity: 99%
  • Soluble in DMSO
Recently added

Tafamidis

Description

Tafamids is a small-molecule inhibitor that binds selectively to the transthyretin (TTR) protein in human plasma and kinetically stabilizes the tetrameric structure of both wild-type TTR and a number of different mutants. Tafamidis is an oral medication for treating cardiomyopathy and peripheral neuropathy due to transthyretin amyloidosis (ATTR). It is a transthyretin stabilizer and has been shown to reduce disease progression and mortality significantly.

KEYWORDS: Tafamidis | Supplier | Selective TTR stabilizer | CAS [594839-88-0] | Transthyretin | Unclassified | Inhibitor | Proteins

Order
Size Unit Price Stock
10 mg €90.00 In Stock
50 mg €270.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...